Terbinafine and condition aggravated Patient Reports February 10, 2010

Terbinafine Side Effects Report #5672640-3
Terbinafine side effect was reported by a Health Professional from FRANCE on Mar 11, 2008. Male patient, 77 years of age, was diagnosed with trichophytosis, mycosis fungoides and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: condition aggravated, lymphoma , mycosis fungoides stage iv, sezary cells increased. Terbinafine dosage: 250 MG/DAY. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, KETOCONAZOLE. Patient recovered.

Terbinafine Side Effects Report #5512427-5
Terbinafine side effect was reported by a Health Professional from UNITED KINGDOM on Oct 22, 2007. Male patient, 46 years of age, was diagnosed with tinea pedis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: condition aggravated, psoriasis, skin exfoliation, vasculitic rash. Terbinafine dosage: 250 MG ORAL. During the same period patient was treated with CLOFIBRATE, GLIMEPIRIDE, METFORMIN, RAMIPRIL. Patient was hospitalized. Patient recovered.

Terbinafine Side Effects Report #5518068-8
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 31, 2007. Male patient, 46 years of age, was diagnosed with tinea pedis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: condition aggravated, psoriasis, skin exfoliation, vasculitic rash. Terbinafine dosage: 250 MG; PO. During the same period patient was treated with CLOFIBRATE, GLIMEPIRIDE, METFORMIN, RAMIPRIL. Patient was hospitalized. Patient recovered.

Terbinafine Side Effects Report #5528021-6
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 22, 2007. Male patient, 46 years of age, was diagnosed with tinea pedis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: condition aggravated, psoriasis, skin exfoliation, vasculitic rash. Terbinafine dosage: 250 MG; ORAL. During the same period patient was treated with CLOFIBRATE, GLIMEPIRIDE, METFORMIN, RAMIPRIL. Patient was hospitalized. Patient recovered.


Terbinafine Side Effects Report #5501644-6
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 12, 2007. Male patient, 50 years of age, was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: blister, condition aggravated, cutaneous lupus erythematosus, rash . Terbinafine dosage: 250 MG ORAL. During the same period patient was treated with MERACRINE. Patient recovered.

Terbinafine Side Effects Report #5839483-9
Terbinafine side effect was reported by a Health Professional from UNITED KINGDOM on July 23, 2008. Female patient was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: arthritis , condition aggravated, cutaneous lupus erythematosus, erythema multiforme, leukopenia, myocardial infarction. Terbinafine dosage: unknown. Patient died on 01/01/2007.

Terbinafine Side Effects Report #5224751-4
Terbinafine side effect was reported by a Health Professional from BELGIUM on Dec 14, 2006. Male patient, 45 years of age, was diagnosed with fungal skin infection and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, condition aggravated, fungal skin infection, malaise, pyrexia, skin hyperpigmentation. Terbinafine dosage: 250 MG/D. Patient recovered.

Terbinafine Side Effects Report #4773309-X
Terbinafine side effect was reported by a Consumer or non-health professional from JAPAN on Sept 14, 2005. Female patient, 66 years of age, was diagnosed with fungal infection  and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: brain abscess, condition aggravated, lung abscess. Terbinafine dosage: 125-250 MG/DAY. During the same period patient was treated with AMPHOTERICIN B, FLUCYTOSINE, ITRACONAZOLE. Patient died on 08/01/2003.